Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight
Executive Summary
Fighting misinformation likely will not be successful, the FDA commissioner concedes, but stakeholders should join the campaign to increase the dissemination of truthful information.
You may also be interested in...
Pharma Could Lose Some Commercial Info Protections As Part of FDA’s Misinformation Campaign
Commissioner says agency’s speech restrictions to protect confidential commercial information ‘have gone too far,’ and may need to be modified to tackle spread of misinformation. Experts also said US FDA needs to do a better job conveying the uncertainty inherent in its work.
Prebunk: FDA Needs To Get Ahead Of Misinformation, But It Likely Can’t Drive The Effort
New report offers a five-point plan for FDA to improve the public’s understanding of its role including pushing the agency to be more proactive in listening for, spotting, and addressing misconceptions before they escalate. But experts caution that this must be done carefully, or it could fuel more distrust.
‘We Don’t Hold Regulatory Actions For Press’ – Inside FDA’s Communications Difficulties And Misinformation Fights
Internal US FDA emails illustrate the difficulties coordinating regulatory decisions and communications about them as the agency considers growing its allies in the war against misinformation.